141 related articles for article (PubMed ID: 23923348)
1. Is diarrhea-predominant irritable bowel syndrome a low-grade gut inflammatory disorder?
Ghoshal UC
Trop Gastroenterol; 2012; 33(4):239-41. PubMed ID: 23923348
[No Abstract] [Full Text] [Related]
2. Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients.
Rana SV; Sharma S; Sinha SK; Parsad KK; Malik A; Singh K
Trop Gastroenterol; 2012; 33(4):251-6. PubMed ID: 23923350
[TBL] [Abstract][Full Text] [Related]
3. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome.
Sidhu R; McAlindon ME; Leeds JS; Skilling J; Sanders DS
J Gastrointestin Liver Dis; 2009 Mar; 18(1):23-6. PubMed ID: 19337629
[TBL] [Abstract][Full Text] [Related]
4. [Irritable bowel syndrome--irritable bowel or irritable mind?].
Marlicz W; Zawada I; Starzyńska T
Pol Merkur Lekarski; 2012 Jan; 32(187):64-9. PubMed ID: 22400184
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.
Matsueda K; Harasawa S; Hongo M; Hiwatashi N; Sasaki D
Scand J Gastroenterol; 2008; 43(10):1202-11. PubMed ID: 18618371
[TBL] [Abstract][Full Text] [Related]
6. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
[TBL] [Abstract][Full Text] [Related]
7. Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):858. PubMed ID: 31377275
[No Abstract] [Full Text] [Related]
8. AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):851-854. PubMed ID: 31302098
[No Abstract] [Full Text] [Related]
9. Irritable bowel syndrome and diverticular disease: association or misdiagnosis?
Tursi A
Am J Gastroenterol; 2010 Oct; 105(10):2293; author reply 2293-4. PubMed ID: 20927068
[No Abstract] [Full Text] [Related]
10. [Cholagenic diarrhea is a type of postcholescystectomy syndrome].
Krums LM; Parfenov AI; Gubina AV; Sil'vestrova SIu; Smirnova AV
Ter Arkh; 2013; 85(2):32-5. PubMed ID: 23653936
[TBL] [Abstract][Full Text] [Related]
11. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.
Scully P; McKernan DP; Keohane J; Groeger D; Shanahan F; Dinan TG; Quigley EM
Am J Gastroenterol; 2010 Oct; 105(10):2235-43. PubMed ID: 20407431
[TBL] [Abstract][Full Text] [Related]
12. Lower gastrointestinal disorders in patients with irritable bowel syndrome.
Jurcić D; Bilić A; Schwarz D; Luetic K; Marusić M; Vcev A; Gabrić M; Spoljarić L
Coll Antropol; 2008 Sep; 32(3):755-9. PubMed ID: 18982748
[TBL] [Abstract][Full Text] [Related]
13. AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D): Patient Summary.
American Gastroenterological Association
Gastroenterology; 2019 Sep; 157(3):856-857. PubMed ID: 31378676
[No Abstract] [Full Text] [Related]
14. Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes.
Bleser S
Curr Med Res Opin; 2011 Mar; 27(3):503-12. PubMed ID: 21208139
[TBL] [Abstract][Full Text] [Related]
15. Undiagnosed Exocrine Pancreatic Insufficiency in Diarrhea-Predominant Irritable Bowel Syndrome.
Lee AA; McNabb-Baltar J
Dig Dis Sci; 2022 Dec; 67(12):5364-5365. PubMed ID: 35705731
[No Abstract] [Full Text] [Related]
16. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?
Dinan TG; Quigley EM; Ahmed SM; Scully P; O'Brien S; O'Mahony L; O'Mahony S; Shanahan F; Keeling PW
Gastroenterology; 2006 Feb; 130(2):304-11. PubMed ID: 16472586
[TBL] [Abstract][Full Text] [Related]
17. Upper GI symptoms in patients with irritable bowel syndrome.
Mann NS
Am J Gastroenterol; 2004 Jun; 99(6):1191; author reply 1192. PubMed ID: 15180743
[No Abstract] [Full Text] [Related]
18. Persistent diarrhoea in a young woman.
Ramnarace R; Ricketts J; Dalton H
BMJ; 2009 Sep; 339():b3369. PubMed ID: 19759088
[No Abstract] [Full Text] [Related]
19. Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy.
Long MD; Drossman DA
Am J Gastroenterol; 2010 Aug; 105(8):1796-8. PubMed ID: 20686466
[TBL] [Abstract][Full Text] [Related]
20. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
